Jump to main content
Jump to site search

Issue 40, 2013
Previous Article Next Article

Disulfide bond reduction-triggered molecular hydrogels of folic acid–Taxol conjugates

Author affiliations

Abstract

Molecular hydrogels of therapeutic agents are a novel kind of self-delivery system that can sustain release of drugs or pro-drugs. We have previously developed a molecular hydrogelator of folic acid (FA)–Taxol conjugate triggered by phosphatase. In this paper, we report a novel molecular hydrogelator system of FA–Taxol conjugates with improved synthetic strategy. The hydrogels are formed by the reduction of disulfide bond by glutathione (GSH). These hydrogels could sustain release of Taxol through ester bond hydrolysis. Compared with intravenous (i.v.) injection of clinically used Taxol® with four times the dosage, our hydrogel could inhibit tumor growth more efficiently by a single dose of intra-tumor (i.t.) administration. These observations suggested the big potential of this novel gelation system of Taxol for cancer therapy.

Graphical abstract: Disulfide bond reduction-triggered molecular hydrogels of folic acid–Taxol conjugates

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 08 May 2013, accepted on 02 Aug 2013 and first published on 05 Aug 2013


Article type: Paper
DOI: 10.1039/C3OB40969D
Citation: Org. Biomol. Chem., 2013,11, 6946-6951
  •   Request permissions

    Disulfide bond reduction-triggered molecular hydrogels of folic acid–Taxol conjugates

    C. Yang, D. Li, Q. FengZhao, L. Wang, L. Wang and Z. Yang, Org. Biomol. Chem., 2013, 11, 6946
    DOI: 10.1039/C3OB40969D

Search articles by author